Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | H002 |
Trade Name | |
Synonyms | H-002|H 002 |
Drug Descriptions |
H002 is a 4th-generation EGFR inhibitor, with activity against multiple EGFR mutations, which may lead lead to decreased tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 5461). |
DrugClasses | EGFR Inhibitor 4th gen 16 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
H002 | H002 | 0 | 1 |